-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NuT7aQ60wfLjIfnJgFg5aqjTui1xFEdv4bTY+zNBnrDEqebTsndmFVIlmSyFa6g+ wEBafhrQLfd/SLKtOx8HMg== 0001179110-09-016227.txt : 20091203 0001179110-09-016227.hdr.sgml : 20091203 20091203155221 ACCESSION NUMBER: 0001179110-09-016227 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091201 FILED AS OF DATE: 20091203 DATE AS OF CHANGE: 20091203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YOUNG KEVIN CENTRAL INDEX KEY: 0001303643 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 091220193 MAIL ADDRESS: STREET 1: GILEAD SCIENCES, INC. STREET 2: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94015 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 edgar.xml FORM 4 - X0303 4 2009-12-01 0 0000882095 GILEAD SCIENCES INC GILD 0001303643 YOUNG KEVIN GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 0 1 0 0 EVP, Commercial Operations Common Stock 2009-12-01 4 M 0 43086 16.010 A 63433 D Common Stock 2009-12-01 4 M 0 31914 17.6750 A 95347 D Common Stock 2009-12-01 4 S 0 75000 45.8019 D 20347 D Non-Qualified Stock Option (right to buy) 16.0100 2009-12-01 4 M 0 43086 0 D 2015-01-26 Common Stock 43086 6254 D Non-Qualified Stock Option (right to buy) 17.6750 2009-12-01 4 M 0 31914 0 D 2014-11-02 Common Stock 31914 81876 D The options have a five year vesting schedule. 20% of the options vested on January 26, 2006, the first anniversary date of the grant. The balance will vest 5% every three months thereafter until fully vested on January 26, 2010. The options have a five year vesting schedule. 20% of the options vested on November 2, 2005, the first anniversary date of the grant. The balance vested 5% every three months thereafter until fully vested on November 2, 2009. Sale prices reported for the transactions reported here range from $45.64 to $45.97. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. The exercise and sale transactions reported in this Form 4 made pursuant to a Rule 10b5-1 trading plan established by Mr. Young on August 26, 2009. /s/ Kevin Young 2009-12-02 -----END PRIVACY-ENHANCED MESSAGE-----